カテゴリ： 世界, 医療/バイオ, Market Monitor Global

アジュバント使用インフルエンザワクチンのグローバル市場展望 2023年-2029年：バイアル、充填済み

■ 英語タイトル：Adjuvanted Influenza Vaccine Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14210）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14210
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：79
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[アジュバント使用インフルエンザワクチンのグローバル市場展望 2023年-2029年：バイアル、充填済み]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のアジュバント使用インフルエンザワクチン市場規模と予測を収録しています。・世界のアジュバント使用インフルエンザワクチン市場：売上、2018年-2023年、2024年-2029年
・世界のアジュバント使用インフルエンザワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のアジュバント使用インフルエンザワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「バイアル」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

アジュバント使用インフルエンザワクチンのグローバル主要企業は、CSLなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、アジュバント使用インフルエンザワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のアジュバント使用インフルエンザワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界のアジュバント使用インフルエンザワクチン市場：タイプ別市場シェア、2022年
・バイアル、充填済み

世界のアジュバント使用インフルエンザワクチン市場：用途別、2018年-2023年、2024年-2029年
世界のアジュバント使用インフルエンザワクチン市場：用途別市場シェア、2022年
・公共、民間

世界のアジュバント使用インフルエンザワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界のアジュバント使用インフルエンザワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるアジュバント使用インフルエンザワクチンのグローバル売上、2018年-2023年
・主要企業におけるアジュバント使用インフルエンザワクチンのグローバル売上シェア、2022年
・主要企業におけるアジュバント使用インフルエンザワクチンのグローバル販売量、2018年-2023年
・主要企業におけるアジュバント使用インフルエンザワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
CSL

*************************************************************

・調査・分析レポートの概要
アジュバント使用インフルエンザワクチン市場の定義
市場セグメント
世界のアジュバント使用インフルエンザワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のアジュバント使用インフルエンザワクチン市場規模
世界のアジュバント使用インフルエンザワクチン市場規模：2022年 VS 2029年
世界のアジュバント使用インフルエンザワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのアジュバント使用インフルエンザワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のアジュバント使用インフルエンザワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：バイアル、充填済み
アジュバント使用インフルエンザワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：公共、民間
アジュバント使用インフルエンザワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別アジュバント使用インフルエンザワクチン市場規模 2022年と2029年
地域別アジュバント使用インフルエンザワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
CSL
...

This research report provides a comprehensive analysis of the Adjuvanted Influenza Vaccine market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Adjuvanted Influenza Vaccine market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Adjuvanted Influenza Vaccine, challenges faced by the industry, and potential opportunities for market players.
The global Adjuvanted Influenza Vaccine market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Adjuvanted Influenza Vaccine market presents opportunities for various stakeholders, including Public Sector, Private Sector. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Adjuvanted Influenza Vaccine market. Additionally, the growing consumer demand present avenues for market expansion.
The global Adjuvanted Influenza Vaccine market was valued at US$ 898.2 million in 2022 and is projected to reach US$ 2128.8 million by 2029, at a CAGR of 12.8% during the forecast period.
A significant driver in the Influenza Vaccine market is the growing awareness of the importance of vaccination in preventing seasonal and pandemic influenza outbreaks. As healthcare organizations and governments worldwide promote vaccination as a crucial public health measure, there is an increasing demand for influenza vaccines. Additionally, advances in vaccine research and development, including the production of more effective and broader-spectrum vaccines, are driving market growth. One of the key challenges in this market is the need for frequent vaccine updates to match evolving influenza strains. The virus undergoes genetic changes, requiring annual adjustments to vaccine formulations. This presents logistical challenges for manufacturers in terms of timely production and distribution. Vaccine hesitancy and misinformation also pose challenges by impacting vaccination rates and public perception. Lastly, ensuring equitable access to vaccines, especially in low-income and underserved populations, remains a persistent challenge in the fight against influenza.
Key Features:
The research report on the Adjuvanted Influenza Vaccine market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Adjuvanted Influenza Vaccine market.
Market Overview: The report provides a comprehensive overview of the Adjuvanted Influenza Vaccine market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Vial, Prefilled), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Adjuvanted Influenza Vaccine market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Adjuvanted Influenza Vaccine market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Adjuvanted Influenza Vaccine market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Adjuvanted Influenza Vaccine market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Adjuvanted Influenza Vaccine market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Adjuvanted Influenza Vaccine market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Adjuvanted Influenza Vaccine, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Adjuvanted Influenza Vaccine market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Adjuvanted Influenza Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Vial
Prefilled
Market segment by Application
Public Sector
Private Sector
Global Adjuvanted Influenza Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
CSL
Outline of Major Chapters:
Chapter 1: Introduces the definition of Adjuvanted Influenza Vaccine, market overview.
Chapter 2: Global Adjuvanted Influenza Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Adjuvanted Influenza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Adjuvanted Influenza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Adjuvanted Influenza Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Adjuvanted Influenza Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Adjuvanted Influenza Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Adjuvanted Influenza Vaccine Overall Market Size
2.1 Global Adjuvanted Influenza Vaccine Market Size: 2022 VS 2029
2.2 Global Adjuvanted Influenza Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Adjuvanted Influenza Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Adjuvanted Influenza Vaccine Players in Global Market
3.2 Top Global Adjuvanted Influenza Vaccine Companies Ranked by Revenue
3.3 Global Adjuvanted Influenza Vaccine Revenue by Companies
3.4 Global Adjuvanted Influenza Vaccine Sales by Companies
3.5 Global Adjuvanted Influenza Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Adjuvanted Influenza Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Adjuvanted Influenza Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Adjuvanted Influenza Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Adjuvanted Influenza Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Adjuvanted Influenza Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Adjuvanted Influenza Vaccine Market Size Markets, 2022 & 2029
4.1.2 Vial
4.1.3 Prefilled
4.2 By Type – Global Adjuvanted Influenza Vaccine Revenue & Forecasts
4.2.1 By Type – Global Adjuvanted Influenza Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Adjuvanted Influenza Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Adjuvanted Influenza Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Adjuvanted Influenza Vaccine Sales & Forecasts
4.3.1 By Type – Global Adjuvanted Influenza Vaccine Sales, 2018-2023
4.3.2 By Type – Global Adjuvanted Influenza Vaccine Sales, 2024-2029
4.3.3 By Type – Global Adjuvanted Influenza Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Adjuvanted Influenza Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Adjuvanted Influenza Vaccine Market Size, 2022 & 2029
5.1.2 Public Sector
5.1.3 Private Sector
5.2 By Application – Global Adjuvanted Influenza Vaccine Revenue & Forecasts
5.2.1 By Application – Global Adjuvanted Influenza Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Adjuvanted Influenza Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Adjuvanted Influenza Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Adjuvanted Influenza Vaccine Sales & Forecasts
5.3.1 By Application – Global Adjuvanted Influenza Vaccine Sales, 2018-2023
5.3.2 By Application – Global Adjuvanted Influenza Vaccine Sales, 2024-2029
5.3.3 By Application – Global Adjuvanted Influenza Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Adjuvanted Influenza Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Adjuvanted Influenza Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Adjuvanted Influenza Vaccine Revenue & Forecasts
6.2.1 By Region – Global Adjuvanted Influenza Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Adjuvanted Influenza Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Adjuvanted Influenza Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Adjuvanted Influenza Vaccine Sales & Forecasts
6.3.1 By Region – Global Adjuvanted Influenza Vaccine Sales, 2018-2023
6.3.2 By Region – Global Adjuvanted Influenza Vaccine Sales, 2024-2029
6.3.3 By Region – Global Adjuvanted Influenza Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Adjuvanted Influenza Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Adjuvanted Influenza Vaccine Sales, 2018-2029
6.4.3 US Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.4.4 Canada Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.4.5 Mexico Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Adjuvanted Influenza Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Adjuvanted Influenza Vaccine Sales, 2018-2029
6.5.3 Germany Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.5.4 France Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.5.5 U.K. Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.5.6 Italy Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.5.7 Russia Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.5.9 Benelux Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Adjuvanted Influenza Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Adjuvanted Influenza Vaccine Sales, 2018-2029
6.6.3 China Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.6.4 Japan Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.6.5 South Korea Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.6.7 India Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Adjuvanted Influenza Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Adjuvanted Influenza Vaccine Sales, 2018-2029
6.7.3 Brazil Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.7.4 Argentina Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Adjuvanted Influenza Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Adjuvanted Influenza Vaccine Sales, 2018-2029
6.8.3 Turkey Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.8.4 Israel Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.8.6 UAE Adjuvanted Influenza Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 CSL
7.1.1 CSL Company Summary
7.1.2 CSL Business Overview
7.1.3 CSL Adjuvanted Influenza Vaccine Major Product Offerings
7.1.4 CSL Adjuvanted Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 CSL Key News & Latest Developments
8 Global Adjuvanted Influenza Vaccine Production Capacity, Analysis
8.1 Global Adjuvanted Influenza Vaccine Production Capacity, 2018-2029
8.2 Adjuvanted Influenza Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Adjuvanted Influenza Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Adjuvanted Influenza Vaccine Supply Chain Analysis
10.1 Adjuvanted Influenza Vaccine Industry Value Chain
10.2 Adjuvanted Influenza Vaccine Upstream Market
10.3 Adjuvanted Influenza Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Adjuvanted Influenza Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Adjuvanted Influenza Vaccine in Global Market
Table 2. Top Adjuvanted Influenza Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Adjuvanted Influenza Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Adjuvanted Influenza Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Adjuvanted Influenza Vaccine Sales by Companies, (K Units), 2018-2023
Table 6. Global Adjuvanted Influenza Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Adjuvanted Influenza Vaccine Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Adjuvanted Influenza Vaccine Product Type
Table 9. List of Global Tier 1 Adjuvanted Influenza Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Adjuvanted Influenza Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Adjuvanted Influenza Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Adjuvanted Influenza Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Adjuvanted Influenza Vaccine Sales (K Units), 2018-2023
Table 15. By Type - Global Adjuvanted Influenza Vaccine Sales (K Units), 2024-2029
Table 16. By Application – Global Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Adjuvanted Influenza Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Adjuvanted Influenza Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Adjuvanted Influenza Vaccine Sales (K Units), 2018-2023
Table 20. By Application - Global Adjuvanted Influenza Vaccine Sales (K Units), 2024-2029
Table 21. By Region – Global Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Adjuvanted Influenza Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Adjuvanted Influenza Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Adjuvanted Influenza Vaccine Sales (K Units), 2018-2023
Table 25. By Region - Global Adjuvanted Influenza Vaccine Sales (K Units), 2024-2029
Table 26. By Country - North America Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Adjuvanted Influenza Vaccine Sales, (K Units), 2018-2023
Table 29. By Country - North America Adjuvanted Influenza Vaccine Sales, (K Units), 2024-2029
Table 30. By Country - Europe Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Adjuvanted Influenza Vaccine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Adjuvanted Influenza Vaccine Sales, (K Units), 2024-2029
Table 34. By Region - Asia Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Adjuvanted Influenza Vaccine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Adjuvanted Influenza Vaccine Sales, (K Units), 2024-2029
Table 38. By Country - South America Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Adjuvanted Influenza Vaccine Sales, (K Units), 2018-2023
Table 41. By Country - South America Adjuvanted Influenza Vaccine Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Adjuvanted Influenza Vaccine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Adjuvanted Influenza Vaccine Sales, (K Units), 2024-2029
Table 46. CSL Company Summary
Table 47. CSL Adjuvanted Influenza Vaccine Product Offerings
Table 48. CSL Adjuvanted Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. CSL Key News & Latest Developments
Table 50. Adjuvanted Influenza Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 51. Global Adjuvanted Influenza Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 52. Global Adjuvanted Influenza Vaccine Production by Region, 2018-2023 (K Units)
Table 53. Global Adjuvanted Influenza Vaccine Production by Region, 2024-2029 (K Units)
Table 54. Adjuvanted Influenza Vaccine Market Opportunities & Trends in Global Market
Table 55. Adjuvanted Influenza Vaccine Market Drivers in Global Market
Table 56. Adjuvanted Influenza Vaccine Market Restraints in Global Market
Table 57. Adjuvanted Influenza Vaccine Raw Materials
Table 58. Adjuvanted Influenza Vaccine Raw Materials Suppliers in Global Market
Table 59. Typical Adjuvanted Influenza Vaccine Downstream
Table 60. Adjuvanted Influenza Vaccine Downstream Clients in Global Market
Table 61. Adjuvanted Influenza Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Adjuvanted Influenza Vaccine Segment by Type in 2022
Figure 2. Adjuvanted Influenza Vaccine Segment by Application in 2022
Figure 3. Global Adjuvanted Influenza Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Adjuvanted Influenza Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Adjuvanted Influenza Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Adjuvanted Influenza Vaccine Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Adjuvanted Influenza Vaccine Revenue in 2022
Figure 9. By Type - Global Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Adjuvanted Influenza Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Adjuvanted Influenza Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Adjuvanted Influenza Vaccine Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Adjuvanted Influenza Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Adjuvanted Influenza Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Adjuvanted Influenza Vaccine Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Adjuvanted Influenza Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Adjuvanted Influenza Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Adjuvanted Influenza Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Adjuvanted Influenza Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Adjuvanted Influenza Vaccine Sales Market Share, 2018-2029
Figure 23. US Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Adjuvanted Influenza Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Adjuvanted Influenza Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Adjuvanted Influenza Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Adjuvanted Influenza Vaccine Sales Market Share, 2018-2029
Figure 37. China Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Adjuvanted Influenza Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Adjuvanted Influenza Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Adjuvanted Influenza Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Adjuvanted Influenza Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Adjuvanted Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Adjuvanted Influenza Vaccine Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Adjuvanted Influenza Vaccine by Region, 2022 VS 2029
Figure 54. Adjuvanted Influenza Vaccine Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）のグローバル市場展望 2023年-2029年：バイアル、充填済み
  • 組換え活性型凝固第VII因子のグローバル市場展望 2023年-2029年：バイアル、プレフィルドシリンジ
  • 組換えヒト凝固VIIaの世界市場2023年：プレフィルドシリンジ、バイアル
  • 小児用インフルエンザワクチンのグローバル市場展望 2023年-2029年：点鼻薬、注射
  • インフルエンザワクチンのグローバル市場展望 2023年-2029年：3価インフルエンザワクチン、4価インフルエンザワクチン
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14210 )"アジュバント使用インフルエンザワクチンのグローバル市場展望 2023年-2029年：バイアル、充填済み" (英文：Adjuvanted Influenza Vaccine Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。